Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000177

Chairperson & CEO sold 9,500 shares at an average $596.22 ($5,664,136)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-02 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-11-02 Sale : show line 2 in the form 10b5-1 −223 $593.09 $132,259 333,720 I
2026-11-02 Sale : show line 3 in the form 10b5-1 −905 $594.03 $537,597 332,815 I
2026-11-02 Sale : show line 4 in the form 10b5-1 −1,599 $595.15 $951,644 331,216 I
2026-11-02 Sale : show line 5 in the form 10b5-1 −2,776 $596.11 $1,654,807 328,440 I
2026-11-02 Sale : show line 6 in the form 10b5-1 −2,517 $597.02 $1,502,690 325,923 I
2026-11-02 Sale : show line 7 in the form 10b5-1 −1,280 $597.95 $765,371 324,643 I
2026-11-02 Sale : show line 8 in the form 10b5-1 −200 $598.84 $119,768 324,443 I
Open-market sales · 9,500 sh · avg $596.22 · $5,664,136

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-02 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option −9,500 109,910 I
Loading xslF345X06/primarydocument.xml…